Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) CEO Christopher Bilotto acquired 20,000 shares of the stock in a transaction dated Monday, December 15th. The shares were bought at an average price of $4.89 per share, with a total value of $97,800.00. Following the completion of the purchase, the chief executive officer directly owned 266,285 shares of the company’s stock, valued at approximately $1,302,133.65. This trade represents a 8.12% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Diversified Healthcare Trust Stock Performance
Shares of NASDAQ DHC traded down $0.09 during mid-day trading on Tuesday, hitting $4.82. The stock had a trading volume of 717,216 shares, compared to its average volume of 897,762. The firm has a market cap of $1.17 billion, a PE ratio of -3.30 and a beta of 2.39. The company has a debt-to-equity ratio of 1.61, a quick ratio of 16.89 and a current ratio of 16.89. The company has a 50 day moving average of $4.47 and a two-hundred day moving average of $4.00. Diversified Healthcare Trust has a twelve month low of $2.00 and a twelve month high of $5.00.
Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) last announced its quarterly earnings data on Monday, June 2nd. The real estate investment trust reported $0.01 earnings per share for the quarter. Diversified Healthcare Trust had a negative return on equity of 18.90% and a negative net margin of 22.90%.The business had revenue of $370.78 million for the quarter.
Diversified Healthcare Trust Announces Dividend
Analyst Upgrades and Downgrades
Several research firms recently commented on DHC. B. Riley reaffirmed a “buy” rating and set a $6.50 target price (up from $5.50) on shares of Diversified Healthcare Trust in a report on Monday. Royal Bank Of Canada raised shares of Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and lifted their target price for the company from $3.00 to $5.00 in a report on Thursday, November 13th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $5.75.
Read Our Latest Stock Report on DHC
Institutional Trading of Diversified Healthcare Trust
Large investors have recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new stake in Diversified Healthcare Trust in the second quarter valued at approximately $28,000. Farther Finance Advisors LLC grew its position in shares of Diversified Healthcare Trust by 169.2% during the second quarter. Farther Finance Advisors LLC now owns 10,161 shares of the real estate investment trust’s stock worth $36,000 after acquiring an additional 6,387 shares during the last quarter. Brooklyn Investment Group increased its holdings in shares of Diversified Healthcare Trust by 296.3% in the 1st quarter. Brooklyn Investment Group now owns 18,174 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 13,588 shares during the period. Ground Swell Capital LLC acquired a new stake in Diversified Healthcare Trust during the 3rd quarter worth $45,000. Finally, Smith Asset Management Co. LLC purchased a new position in Diversified Healthcare Trust during the 1st quarter worth $56,000. 75.98% of the stock is currently owned by hedge funds and other institutional investors.
About Diversified Healthcare Trust
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.
Featured Articles
- Five stocks we like better than Diversified Healthcare Trust
- How to trade using analyst ratings
- RTX Surges to Record Highs as Defense Orders Explode
- 10 Best Airline Stocks to Buy
- Smart Money Is Buying Auto Suppliers, Not Car Brands
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Higher Beef Prices Are Here: Best Steakhouse Stocks for 2026
Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
